BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 29522636)

  • 1. [Treatment-resistant schizophrenia: Neutropenia with olanzapine and clozapine, and stabilization with two depot antipsychotics].
    Alba P
    Vertex; 2017 Mar; 28(132):141-144. PubMed ID: 29522636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible delayed onset olanzapine-associated leukopenia and neutropenia in a clozapine-naive patient on concomitant depot antipsychotic.
    Thinn SS; Liew E; May AL; Chua HC; Sim K
    J Clin Psychopharmacol; 2007 Aug; 27(4):394-5. PubMed ID: 17632225
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolongation of clozapine-induced neutropenia with olanzapine.
    Jagadheesan K; Mehrtens J
    Aust N Z J Psychiatry; 2007 Feb; 41(2):192. PubMed ID: 17464699
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversible neutropenia with olanzapine following clozapine-induced neutropenia.
    Thangadurai P; Jyothi KS; Gopalakrishnan R; Kuruvilla A; Jacob KS
    Am J Psychiatry; 2006 Jul; 163(7):1298. PubMed ID: 16816247
    [No Abstract]   [Full Text] [Related]  

  • 5. Olanzapine-induced neutropenia in patients with history of clozapine treatment: two case reports from a state psychiatric institution.
    Teter CJ; Early JJ; Frachtling RJ
    J Clin Psychiatry; 2000 Nov; 61(11):872-3. PubMed ID: 11105743
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effectiveness of antipsychotics in schizophrenia and related disorders. Results of a naturalistic study].
    Carpiniello B; Mellino G; Pintore S; Puddu L; Pinna F
    Clin Ter; 2011; 162(4):331-41. PubMed ID: 21912821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolongation of clozapine-induced leukopenia with olanzapine treatment.
    Sayin A; Cosar B
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):958-9. PubMed ID: 16631295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quetiapine XR-induced neutropenia: is a clozapine trial still possible for treatment-resistant schizophrenia? A case report.
    Crépeau-Gendron G; L'Heureux S
    Early Interv Psychiatry; 2015 Apr; 9(2):151-5. PubMed ID: 24690066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hematological alterations associated to olanzapine use after clozapine-induced neutropenia].
    Cabral CG; de Castro M; das Neves L; Nicolato R; Lauar H; Salgado JV
    Braz J Psychiatry; 2007 Mar; 29(1):93. PubMed ID: 17435944
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversible neutropenia during treatment with olanzapine: three case reports.
    Cordes J; Streit M; Loeffler S; von Wilmsdorff M; Agelink M; Klimke A
    World J Biol Psychiatry; 2004 Oct; 5(4):230-4. PubMed ID: 15543518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland.
    Ingimarsson O; MacCabe JH; Haraldsson M; Jónsdóttir H; Sigurdsson E
    BMC Psychiatry; 2016 Dec; 16(1):441. PubMed ID: 27955666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review].
    Simon L; Cazard F
    Encephale; 2016 Aug; 42(4):346-53. PubMed ID: 27109327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine-induced neutropenia after clozapine-induced neutropenia.
    Benedetti F; Cavallaro R; Smeraldi E
    Lancet; 1999 Aug; 354(9178):567. PubMed ID: 10470706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neutropenia in a patient treated with clozapine in combination with other psychotropic drugs].
    Sénéchal A; Landry P; Deschamps R; Lessard M
    Encephale; 2002; 28(6 Pt 1):567-9. PubMed ID: 12506270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia.
    Bitter I; Dossenbach MR; Brook S; Feldman PD; Metcalfe S; Gagiano CA; Füredi J; Bartko G; Janka Z; Banki CM; Kovacs G; Breier A;
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):173-80. PubMed ID: 14687871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.
    Lambert BL; Chou CH; Chang KY; Tafesse E; Carson W
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):417-25. PubMed ID: 15786516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
    Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
    JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine re-challenge under the cover of Filgrastim.
    Gopalakrishnan R; Subhalakshmi TP; Kuruvilla A; Jacob KS
    J Postgrad Med; 2013; 59(1):54-5. PubMed ID: 23525060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine-induced neutropenia in children: management with lithium carbonate.
    Sporn A; Gogtay N; Ortiz-Aguayo R; Alfaro C; Tossell J; Lenane M; Gochman P; Rapoport JL
    J Child Adolesc Psychopharmacol; 2003; 13(3):401-4. PubMed ID: 14642024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of blood cell counts with the risk of olanzapine- or clozapine-induced dyslipidemia in Chinese schizophrenia patients.
    Xiong Z; Cheng M; Zhu P; Huang S; Guo J; Zhang W; Zhou H; Shu Y; Li Q
    Hum Psychopharmacol; 2019 Jul; 34(4):e2699. PubMed ID: 31273857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.